Switzerland Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,995	174 Pages	GlobalData	July, 2021	GBDT16727907

Best Price Guarantee
Price	from $1,995
Length	174 Pages
Publisher	GlobalData
Published Date	July, 2021
SKU	GBDT16727907

Switzerland Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Summary

GlobalData, the industry analysis specialist, has released its latest report, “Switzerland Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Switzerland. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Swiss pharmaceutical industry is one of the major industries of the country. In 2020, it amounted to about 27.7% of Switzerland’s total exports, making it the country’s largest exporting industry. In terms of Swiss Francs, the country’s pharmaceutical market increased from CHF5.93B in 2013 to CHF6.84B in 2020. It is estimated to increase at a Compound Annual Growth Rate (CAGR) of 1.9% to CHF7.51B in 2025. In the terms of US dollars, the Swiss pharmaceutical market increased from $6.40B in 2013 to $7.28B in 2020, which is estimated to increase at a CAGR of 1.3% to $7.75B in 2025. High expenditure on pharmaceutical R&D and the presence of major pharmaceutical companies have propelled the growth of the pharmaceutical industry. The medical devices market in Switzerland was valued at $2.27B in 2015, which increased to $2.88B in 2020 at a CAGR of 5%. The market is expected to grow at a CAGR of 3% from $3.18B in 2021 to $3.61B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Switzerland, and includes -

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Pfizer, Novartis, Bayer, and Octapharma.
Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Medtronic, Zimmer Biomet, and Smith-Nephew.
An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in Switzerland healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving Switzerland healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Switzerland healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1.Table of Contents: 1.1 List of Figures; 1.2 List of Tables
2. Executive Summary: 2.1 Executive Summary; 2.2 Key Highlights - Facts about Switzerland Healthcare Market; 2.3 Key Highlights: Healthcare Startups in Switzerland; 2.4 Key Events: Switzerland Pharmaceutical News, 2015-2021; 2.5 Key Events: Switzerland Pharmaceutical Market; 2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020; 2.7 Key Events: Mergers and Acquisitions; 2.8 Country Profile, Switzerland, 2020
3. Overview of Pharmaceutical Market: 3.1 Pharmaceutical Market - Overview; 3.2 Pharmaceutical Market - Key Areas for Building a Strong Pharma hub in Switzerland, Vision: 2030; 3.3 Pharmaceutical Market - Exports; 3.4 Pharmaceutical Market - Imports; 3.5 Pharmaceutical Market - Supply Channels, Switzerland; 3.6 Pharmaceutical Market - Illegal Import of Medicines, Switzerland; 3.7 Pharmaceutical Market - Market Segments; 3.8 Major Therapeutic Areas, Switzerland; 3.9 COVID-19 Epidemiology, Switzerland; 3.10 COVID-19 Impact and Developments, Switzerland; 3.11 COVID-19 Clinical Trials Landscape, Switzerland; 3.12 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market: 4.1 Medical Device Market - Overview; 4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers: 5.1 Drivers; 5.2 Barriers
6. Deal Analysis: 6.1 Deal Analysis: Pharmaceutical Market, Switzerland, 2019-2021; 6.2 Deal Analysis: Medical Device Market, Switzerland, 2019-2021
7. HealthTech Landscape: 7.1 HealthTech Landscape, Switzerland; 7.2 Adoption of Technology in Healthcare, Switzerland; 7.3 HealthTech Deals Landscape, Switzerland; 7.4 Key HealthTech Deals, Switzerland; 7.5 Digital Health Regulations, Switzerland; 7.6 HealthTech Landscape: Benefits and Risks, Switzerland
8. Market Access: 8.1 Overview of Healthcare System, Switzerland; 8.2 Drug Reimbursement Process, Switzerland; 8.3 Overview of Insurance Providers, Switzerland; 8.4 Out-of-Pocket Co-Payments and Safety Nets, Switzerland; 8.5 Out-of-Pocket Spending and Pharmaceutical Price Index, Switzerland; 8.6 Pricing Policies, Switzerland; 8.7 Regulatory Landscape, Switzerland; 8.7.1 Overview of Regulatory Agencies, Switzerland; 8.7.2 Marketing Authorization for Pharmaceutical Products, Switzerland; 8.7.3 Marketing Authorization for Generic Medicines, Switzerland; 8.7.4 Marketing Authorization for Biosimilars, Switzerland; 8.7.5 Marketing Authorization for Medical Devices, Switzerland; 8.7.6 Export and Import Regulations, Switzerland; 8.7.7 Intellectual Property Rights, Patent, Switzerland; 8.7.8 Intellectual Property Rights, Trademark, Switzerland; 8.7.9 Clinical Trial Regulation Process, Switzerland; 8.7.10 Pharmaceutical Clinical Trials Landscape, Switzerland; 8.7.11 Medical Devices Clinical Trials Landscape, Switzerland; 8.7.12 Pharmacy License Regulations, Switzerland; 8.7.13 Online Pharmacy Regulations, Switzerland; 8.7.14 Pharmaceutical Advertisement Regulations, Switzerland; 8.7.15 Labeling and Packaging Regulations, Switzerland
9. Country Healthcare Landscape: 9.1 Healthcare Policy Highlights, Switzerland; 9.2 Healthcare Facilities, Switzerland; 9.3 Healthcare Parameters, Switzerland; 9.4 Life Expectancy and Immunization Rate, Switzerland; 9.5 Environmental Health, Switzerland; 9.6 Healthcare Personnel, Switzerland; 9.7 Disease Burden, US Switzerland; 9.8 Healthcare Expenditure, Switzerland; 9.9 Healthcare Spending Components and Pharmaceutical Spending, Switzerland
11 Trade Associations, Conferences, and Trade Fairs, Switzerland
12 Opportunities and Challenges
13 Appendix: 13.1 Research Methodology; 13.1.1 Coverage; 13.1.2 Secondary Research; 13.1.3 Forecasts; 13.2 Bibliography; 13.3 About GlobalData; 13.4 Contact Us; 13.5 Disclaimer
List of Tables: Table 1: Pharmaceutical Distribution Channels, Switzerland, 2019; Table 2: Confiscated Shipments: Trend Over the Last Three Years, Switzerland, 2018-2020; Table 3: Origin of Illegal Imports by Country/Region, Switzerland, 2019-2020; Table 4: Confiscated Shipments by Product Categories, Switzerland, 2019-2020; Table 5: Approved Biosimilars, Switzerland, 2017-2019; Table 6: Market Share of Medicines by Therapeutic Indicator Areas, Switzerland, 2019; Table 7: COVID-19 Indicators (Number of Cases), Switzerland and Global, January 2020-July 2021; Table 8: COVID-19-Related Travel Restrictions, Switzerland, 2020-2021; Table 9: Available COVID-19-Vaccines, Switzerland, 2020-2021; Table 10: Available COVID-19 IVD products, Switzerland, 2020-2021; Table 11: Medical Devices Market, Switzerland, Major Segments ($M), 2020; Table 12: Hospital Supplies Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 13: General Surgery Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 14: Orthopedic Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 15: In vitro Diagnostic Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 16: Wound care Management Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 17: Licensed Digital Health Technologies, Switzerland, 2014-2017; Table 18: List of Most Expensive and Least Expensive Cantons, Switzerland; Table 19: Typical Patient Copayments and Safety Nets, Switzerland, 2016; Table 20: Fee for Marketing Authorization of Pharmaceutical Products, Switzerland, 2018; Table 21: Patent Application Fee, Switzerland, 2019; Table 22: Trademark Application Fee, Switzerland, 2019; Table 23: Clinical Trial Application Fee, Switzerland, 2019; Table 24: Trade Fairs, Switzerland
List of Figures: Figure 1: Pharmaceutical Market, Switzerland, Revenue ($B and CHF B), 2013-2020; Figure 2: Medical Devices Market, Switzerland, Revenue ($B), 2015-2020; Figure 3: Healthcare Start-Ups in Switzerland, 2020; Figure 4: Country Profile, Switzerland, 2020; Figure 5: Pharmaceutical Market, Switzerland, Revenue ($B), 2011-2020; Figure 6: Pharmaceutical Market, Switzerland, Revenue Forecast ($B), 2021-2025; Figure 7: Key Areas for Building a Strong Pharma Hub, Switzerland, Vision: 2030; Figure 8: Pharmaceutical Exports ($B), Switzerland, 2011-2020; Figure 9: Top Export Partners, Switzerland, 2020; Figure 10: Pharmaceutical Imports ($B), Switzerland, 2011-2020; Figure 11: Top Import Partners, Switzerland, 2020; Figure 12: Pharmaceutical Supply Channel, Switzerland, 2020; Figure 13: Reasons for Gaps in Medicine Supply, Switzerland, 2020; Figure 14: Generic Drugs Usage (% Share by Volume), Switzerland, 2010-2020; Figure 15: Generic Drugs Usage (% Share by Value), Switzerland, 2010-2020; Figure 16: Self-Medication Market, Switzerland, Revenue ($M), 2011-2019; Figure 17: Self-Medication Market by Drug Category, Revenue ($M), Switzerland, 2019; Figure 18: Major Therapeutic Product Categories by Number of Drugs Authorized, Switzerland, 2019; Figure 19: Major Therapeutic Areas by Pharmaceutical Sales ($M), Switzerland, 2018-2020; Figure 20: Market Share of Medicines by Therapeutic Indicator Areas, Switzerland, 2019; Figure 21: COVID-19 (Number of Cases), Switzerland, 2020-2021; Figure 22: COVID-19 (Number of Deaths), Switzerland, 2020-2021; Figure 23: COVID-19 Fiscal Stimulus Timeline, Switzerland, 2020-2021; Figure 24: COVID-19 Vaccine Administration, Number of Vaccines Administered, Switzerland, 2021; Figure 25: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Switzerland, 2020-2021; Figure 26: Top COVID-19 IVD Products by Device Class (Number of Available Marketed Products), Switzerland, 2020-2021; Figure 27: COVID-19 Clinical Trials Sponsors by Count, Switzerland, 2020-2021; Figure 28: COVID-19 Clinical Trials Count by Phase, Switzerland, 2020-2021; Figure 29: COVID-19 Clinical Trials Count by Trial Status, Switzerland, 2020-2021; Figure 30: Medical Devices Market, Switzerland, Revenue ($B), 2015-2020; Figure 31: Medical Devices Market, Switzerland, Revenue Forecast ($B), 2021-2025; Figure 32: Medical Devices Market, Switzerland, Major Segments (%), 2020; Figure 33: Hospital Supplies Market, Switzerland, Revenue ($M), 2015-2022; Figure 34: Hospital Supplies Market, Switzerland, Market Share of Major Players (%), 2020; Figure 35: General Surgery Devices Market, Switzerland, Revenue ($M), 2015-2022; Figure 36: General Surgery Devices Market, Switzerland, Market Share of Major Players (%), 2020; Figure 37: Orthopedic Devices Market, Switzerland, Revenue ($M), 2015-2022; Figure 38: Orthopedic Devices Market, Switzerland, Market Share of Major Players (%), 2020; Figure 39: In vitro Diagnostic Devices Market, Switzerland, Revenue ($M), 2015-2022; Figure 40: In vitro Diagnostic Devices Market, Switzerland, Market Share of Major Players (%), 2020; Figure 41: Wound care Management Devices Market, Switzerland, Revenue ($M), 2015-2022; Figure 42: Wound care Management Devices Market, Switzerland, Market Share of Major Players (%), 2020; Figure 43: Diagnostic Market, Switzerland, Revenue ($M), 2015-2020; Figure 44: Diagnostic Market, Switzerland, Revenue Forecast ($M), 2021-2025; Figure 45: Medical Devices Market, Switzerland, Revenue ($B) of Major Companies, 2020; Figure 46: Deal Value and Deal Count, Pharmaceutical Market, Switzerland, 2019-2021; Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Switzerland, 2019-2021; Figure 48: Deal Value and Deal Count, Subtypes, Pharmaceutical Market, Switzerland, 2019-2021; Figure 49: Top Therapy Areas by Deal Value, Pharmaceutical Market, Switzerland, 2019-2021; Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, Switzerland, 2019-2021; Figure 51: Mergers and Acquisitions by Quarter, Pharmaceutical Market, Switzerland, 2019-2021 (by Value and by Number); Figure 52: Venture Financing by Quarter, Pharmaceutical Market, Switzerland, 2019-2021 (by Value and by Number); Figure 53: Deal Value and Deal Count, Medical Devices Market, Switzerland, 2019-2021; Figure 54: Deal Value and Deal Count, Subtypes, Medical Devices Market, Switzerland, 2019-2021; Figure 55: Deal Value and Deal Count, Quarterly, Medical Devices Market, Switzerland, 2019-2021; Figure 56: Top Equipment Sectors by Deal Value, Medical Devices Market, Switzerland, 2019-2021; Figure 57: Top Equipment Sectors by Deal Count, Medical Devices Market, Switzerland, 2019-2021; Figure 58: Mergers and Acquisitions by Quarter, Medical Devices Market, Switzerland, 2019-2021 (by Value and by Number); Figure 59: Venture Financing by Quarter, Medical Devices Market, Switzerland, 2019-2021 (by Value and by Number); Figure 60: Swiss Digital Health Association Ecosystem, Switzerland, 2020; Figure 61: Industrial Technology Facilities, Switzerland, 2020; Figure 62: Swiss Digital Health Start-Up Map, Switzerland, 2021; Figure 63: Deal Value ($M), HealthTech, Switzerland, 2019-2021; Figure 64: Deal Count (Number of Deals), HealthTech, Switzerland, 2019-2021; Figure 65: Key Health Sector Organizations, Switzerland; Figure 66: Overview of Health System, Switzerland, 2020; Figure 67: Reimbursement Process, Switzerland, 2015; Figure 68: Out-of-Pocket Spending ($ per Capita), Switzerland, 2011-2019; Figure 69: Change in Pharmaceutical Price Index (2015 = 100), Switzerland, 2011-2020; Figure 70: Authorized Medicinal Products by Indications, Swissmedic, Switzerland, 2020; Figure 71: Organization Structure, Swissmedic, Switzerland, 2021